1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow David Hsieh: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma Pembrolizumab, Bavituximab - Hepatocellular Carcinoma | Phase 2 | Completed | David Hsieh | 35 | 2018-04-26 | 2026-07-08 |
bavituximab (1) · pembrolizumab (1)
United States (1)